1
|
Yu X, Lin XJ, Wang S, Liu X, Li W, Kou BX, Chai M, Chen D, Liu X, Wang X. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft. Integr Cancer Ther 2018; 17:1216-1224. [PMID: 29978739 PMCID: PMC6247564 DOI: 10.1177/1534735418785999] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Objective: Huqizhengxiao (HQZX) decoction is a mixture of
traditional Chinese medicines comprising 10 herbs, with inhibitory effects on
hepatocarcinoma. The aim of the study is to observe the antitumor efficacy and
mechanism of HQZX decoction in nude mice with hepatocellular carcinoma
xenografts. Methods: HepG2-luc subcutaneous hepatocarcinoma was
established in nude mice. The mice were divided into 5 groups: control,
cinobufagin, HQZXS, HQZXM, and HQZXH with doses 13.52, 27.03, and 54.06 g/kg,
respectively. HQZX decoction was prepared for intraperitoneal intragastric
administration for 3 weeks. Tumor growth was measured with Vernier calipers and
in vivo imaging system. α-Fetoprotein (AFP) was determined by radioimmunoassay.
Tumor necrosis factor–α (TNF-α) was measured with enzyme-linked immunosorbent
assay (ELISA) assay. Telomerase activity was measured with polymerase chain
reaction–ELISA. Nuclear mitosis and necrosis were observed with
hematoxylin-eosin stain. Apoptotic proteins of caspase-3, Bcl-2, and Bax were
examined by Western blot. Signaling molecules of ERK, mTOR, and STAT3 were
measured with Luminex assay. Results: HQZX decoction showed good
inhibition of HepG2-luc xenografts. Compared with control group, the relative
tumor proliferation rate was less than 60% in the HQZXH and HQZXS. The tumor
inhibition rate of HQZXH group reached 52% ± 15%. Relative average optical
density values of the HQZXS and HQZXH groups decreased significantly. The
mitotic index in HQZXS, HQZXM, and HQZXH groups decreased greatly. Telomerase
activity of HQZXS was clearly reduced, and, the caspase-3 expression upregulated
in HQZXH group. Bcl-2 expression was downregulated in HQZXS and HQZXH. The
ratios of p-ERK/ERK and p-STAT3/STAT3 in HQZXS group were significantly
downregulated. Conclusion: HQZX decoction can clearly inhibit the
growth of hepatocellular carcinoma and induce tumor apoptosis. Its antitumor
mechanism may be related to reducing telomerase activity and regulating the
STAT3 and ERK signal pathway.
Collapse
Affiliation(s)
- XiaoXiao Yu
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Xue-Jun Lin
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Shuang Wang
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China
| | - XiuHong Liu
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - WeiHua Li
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - Bu-Xin Kou
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - MengYin Chai
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - DeXi Chen
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - XiaoNi Liu
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.,2 Beijing Institute of Hepatology, Beijing, People's Republic of China
| | - XiaoJun Wang
- 1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China
| |
Collapse
|
2
|
Wang G. Mechanistic insight into the heme-independent interplay between iron and carbon monoxide in CFTR and Slo1 BK Ca channels. Metallomics 2017; 9:634-645. [PMID: 28474046 DOI: 10.1039/c7mt00065k] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Ion channels have been extensively reported as effectors of carbon monoxide (CO). However, the mechanisms of heme-independent CO action are still not known. Because most ion channels are heterologously expressed on human embryonic kidney cells that are cultured in Fe3+-containing media, CO may act as a small and strong iron chelator to disrupt a putative iron bridge in ion channels and thus to tune their activity. In this review CFTR and Slo1 BKCa channels are employed to discuss the possible heme-independent interplay between iron and CO. Our recent studies demonstrated a high-affinity Fe3+ site at the interface between the regulatory domain and intracellular loop 3 of CFTR. Because the binding of Fe3+ to CFTR prevents channel opening, the stimulatory effect of CO on the Cl- and HCO3- currents across the apical membrane of rat distal colon may be due to the release of inhibitive Fe3+ by CO. In contrast, CO repeatedly stimulates the human Slo1 BKCa channel opening, possibly by binding to an unknown iron site, because cyanide prohibits this heme-independent CO stimulation. Here, in silico research on recent structural data of the slo1 BKCa channels indicates two putative binuclear Fe2+-binding motifs in the gating ring in which CO may compete with protein residues to bind to either Fe2+ bowl to disrupt the Fe2+ bridge but not to release Fe2+ from the channel. Thus, these two new regulation models of CO, with iron releasing from and retaining in the ion channel, may have significant and extensive implications for other metalloproteins.
Collapse
Affiliation(s)
- Guangyu Wang
- Department of Physiology and Membrane Biology, University of California School of Medicine, Davis, CA, USA. and Institute of Biophysical Medico-chemistry, Reno, NV, USA
| |
Collapse
|